Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Renders

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Kidney International|December 1, 1992
Deletions of the COL4A5 gene in patients with Alport syndromeK O Netzer, L Renders, J Zhou, et al.
Clinical Pharmacology and Therapeutics|July 17, 2009
Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokineticsF Braun, H Schöcklmann, E Ziegler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the ratC Daniel, L Renders, K Amann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1999
Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletionI A Hauser, L Renders, H H Radeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2001
Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipientsL Renders, I Mayer-Kadner, C Koch, et al.
Transplantation Proceedings|July 15, 2004
"Very delayed" graft function in a patient after living related kidney transplantation: a case reportC Delles, C Schlüter, M Wittmann, et al.
Clinical Pharmacology and Therapeutics|December 29, 2006
CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipientsL Renders, M Frisman, M Ufer, et al.
Clinical Hemorheology and Microcirculation|January 5, 2012
ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiencesK F Stock, B S Klein, M T Vo Cong, et al.
Clinical Pharmacology and Therapeutics|October 16, 2013
Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearanceA N Werk, S Lefeldt, H Bruckmueller, et al.
Infection|February 2, 2024
Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-upJ Triebelhorn, J Schneider, C D Spinner, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Kidney International|December 1, 1992
Deletions of the COL4A5 gene in patients with Alport syndromeK O Netzer, L Renders, J Zhou, et al.
Clinical Pharmacology and Therapeutics|July 17, 2009
Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokineticsF Braun, H Schöcklmann, E Ziegler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 24, 2005
Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the ratC Daniel, L Renders, K Amann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1999
Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletionI A Hauser, L Renders, H H Radeke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2001
Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipientsL Renders, I Mayer-Kadner, C Koch, et al.
Transplantation Proceedings|July 15, 2004
"Very delayed" graft function in a patient after living related kidney transplantation: a case reportC Delles, C Schlüter, M Wittmann, et al.
Clinical Pharmacology and Therapeutics|December 29, 2006
CYP3A5 genotype markedly influences the pharmacokinetics of tacrolimus and sirolimus in kidney transplant recipientsL Renders, M Frisman, M Ufer, et al.
Clinical Hemorheology and Microcirculation|January 5, 2012
ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiencesK F Stock, B S Klein, M T Vo Cong, et al.
Clinical Pharmacology and Therapeutics|October 16, 2013
Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearanceA N Werk, S Lefeldt, H Bruckmueller, et al.
Infection|February 2, 2024
Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-upJ Triebelhorn, J Schneider, C D Spinner, et al.
Pageof 2